On September 30, 2026, the Justice Department announced that Independence Blue Cross had agreed to pay $22.5 million to resolve False Claims Act allegations involving Medicare Advantage diagnosis data.
The alleged conduct went beyond submitting inaccurate information. DOJ also challenged certifications supporting that information and the retention of overpayments after diagnoses went uncorrected.
The case illustrates why a healthcare organization’s FCA exposure can extend beyond a conventional bill for services. Data can influence what the government pays. Statements can support its reliance on that data. Later information can affect whether the organization is entitled to keep the money.
The case began as a qui tam suit brought by a former IBX employee, who receives $3,825,000 of the settlement. IBX denied the allegations. The settlement contains no admission of liability, and there was no determination of liability. Its significance is the enforcement position it documents.
The Diagnoses Affected Monthly Payments
As DOJ explained, Medicare Advantage plans receive monthly payments adjusted for factors affecting beneficiaries’ expected healthcare costs. Diagnosis codes help CMS calculate those adjustments.
A diagnosis submission therefore has a financial function even though it is not an itemized invoice for treating that condition. Inaccurate diagnoses can inflate the amount Medicare pays a plan.
DOJ alleged that IBX submitted inaccurate diagnosis data, knowingly failed to withdraw that data and repay CMS, and falsely certified its accuracy.
The Review Produced Information in Both Directions
The settlement agreement describes a retrospective review program for service years 2016 through 2020, which DOJ describes as payment years 2017 through 2021. Nurse reviewers examined provider records to identify supported risk-adjusting conditions.
According to the government, IBX used the reviews to add diagnoses that providers had not reported. Some additions increased payment. The reviews also failed to substantiate some diagnoses already submitted, but IBX allegedly did not investigate or withdraw all of those diagnoses and subsequently made false accuracy certifications.
That account raises a concrete question about the use of review findings. What happened when the information pointed toward correcting previously submitted data rather than adding another diagnosis?
The agreement does not supply patient-level examples establishing when a missing diagnosis demonstrated an invalid submission. Nor does it establish a rule that a diagnosis absent from one chart must be deleted. It records the government’s allegations, which IBX expressly denied.
A Claim and a Supporting Statement Are Different Things
The False Claims Act addresses several forms of conduct relevant to this account.
Section 3729(a)(1)(A) concerns knowingly presenting, or causing the presentation of, a false or fraudulent claim for payment or approval. The focus is the claim through which government money is sought.
Section 3729(a)(1)(B) separately concerns knowingly making or causing a false record or statement material to a false or fraudulent claim. The record or statement need not itself request payment. Its role in supporting a false claim matters.
An accuracy certification is therefore not simply another name for a claim. It can provide assurance about information on which payment depends.
Paragraph D of the IBX agreement describes both allegedly submitting or causing false claims and making or causing material false attestations. It does not identify specific statutory counts. Connecting that language to these provisions explains the theories; it does not establish which counts were pleaded or proven.
Keeping the Money Presents Another Question
Section 3729(a)(1)(G), commonly called the reverse-false-claims provision, also reaches knowingly and improperly avoiding or decreasing an obligation to pay the government. That branch does not require a new false claim or false statement. The statute defines an obligation to include the retention of any overpayment.
The agreement expressly describes an alleged avoidance or reduction of a Medicare repayment obligation. DOJ’s announcement likewise emphasizes the alleged failure to correct diagnosis data and repay resulting overpayments.
This is a different inquiry from whether an original submission was knowingly false. Information acquired later can bear on the obligation to return money already received.
An ordinary coding mistake does not, by itself, establish FCA liability. The statute requires the applicable knowledge standard, which includes actual knowledge, deliberate ignorance, and reckless disregard. A review discrepancy must be assessed for what it actually establishes.
